LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: The state of diabetes treatment coverage in 55 low-income and middle-income countries

David Flood, MD / Jacqueline A Seiglie, MD / Matthew Dunn, MPH / Scott Tschida, MPhil / Michaela Theilmann, MA / Maja E Marcus, MA / Garry Brian, MBChB / Bolormaa Norov, MD / Mary T Mayige, PhD / Mongal Singh Gurung, PhD / Krishna K Aryal, PhD / Demetre Labadarios, ProfMBChB / Maria Dorobantu, ProfFESC / Bahendeka K Silver, MBChB / Pascal Bovet, MD / Jutta M Adelin Jorgensen, MD / David Guwatudde, ProfPhD / Corine Houehanou, MD / Glennis Andall-Brereton, PhD /
Sarah Quesnel-Crooks, MSc / Lela Sturua, PhD / Farshad Farzadfar, ProfMD / Sahar Saeedi Moghaddam, MSc / Rifat Atun, ProfFRCP / Sebastian Vollmer, ProfPhD / Till W Bärnighausen, ProfMD / Justine I Davies, ProfMD / Deborah J Wexler, MD / Pascal Geldsetzer, ScD / Peter Rohloff, MD / Manuel Ramírez-Zea, MD / Michele Heisler, ProfMD / Jennifer Manne-Goehler, MD

The Lancet. Healthy Longevity, Vol 2, Iss 6, Pp e340-e

a cross-sectional study of nationally representative, individual-level data in 680 102 adults

2021  Volume 351

Abstract: Summary: Background: Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce ... ...

Abstract Summary: Background: Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns of treatment coverage. The objectives of this study were to estimate the proportion of adults with diabetes in LMICs who receive coverage of recommended pharmacological and non-pharmacological diabetes treatment; and to describe country-level and individual-level characteristics that are associated with treatment. Methods: We did a cross-sectional analysis of pooled, individual data from 55 nationally representative surveys in LMICs. Our primary outcome of self-reported diabetes treatment coverage was based on population-level monitoring indicators recommended in the 2020 WHO Package of Essential Noncommunicable Disease Interventions. Surveys were included if they were done in 2008 or after in an LMIC, as classified by the World Bank in the year the survey was done; were nationally representative; had individual-level data; contained a diabetes biomarker (fasting glucose, random glucose, or glycated haemoglobin); and had data on one or more diabetes treatments. Our sample included non-pregnant individuals with an available diabetes biomarker who were at least 25 years of age. We assessed coverage of three pharmacological and three non-pharmacological treatments among people with diabetes. At the country level, we estimated the proportion of individuals reporting coverage by per-capita gross national income and geographical region. At the individual level, we used logistic regression models to assess coverage along several key individual characteristics including sex, age, body-mass index, wealth quintile, and educational attainment. In the primary analysis, we scaled sample weights such that countries were weighted equally. Findings: The final pooled sample from the 55 LMICs included 680 102 ...
Keywords Geriatrics ; RC952-954.6 ; Medicine ; R
Subject code 360
Language English
Publishing date 2021-06-01T00:00:00Z
Publisher Elsevier
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top